# Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder

> **NCT05818943** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **GRIN Therapeutics, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- GRIN-related Disorders

## Interventions

- **DRUG:** Radiprodil

## Key facts

- **NCT ID:** NCT05818943
- **Lead sponsor:** GRIN Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-07
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05818943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05818943, "Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05818943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*